1Schaefer EJ (2002) Lipoproteins, nutrition, and heart disease. Am J Clin Nutr 75, 191–212.
2Kris-Etherton PM, Harris WS & Appel LJ (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747–2757.
3Griffin BA (1999) Lipoprotein atherogenicity: an overview of current mechanisms. Proc Nutr Soc 58, 163–169.
4Patsch JR, Miesenbock G, Hopferwieser T, et al. (1992) Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12, 1336–1345.
5Roche HM & Gibney MJ (1995) Postprandial triacylglycerolaemia–nutritional implications. Prog Lipid Res 34, 249–266.
6Blackburn P, Cote M, Lamarche B, et al. (2003) Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size. Metabolism 52, 1379–1386.
7El Harchaoui K, van der Steeg WA, Stroes ES, et al. (2007) Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 49, 547–553.
8Hsia J, Otvos JD, Rossouw JE, et al. (2008) Lipoprotein particle concentrations may explain the absence of coronary protection in the women's health initiative hormone trials. Arterioscler Thromb Vasc Biol 28, 1666–1671.
9Packard CJ & Shepherd J (1997) Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 17, 3542–3556.
10Mora S, Szklo M, Otvos JD, et al. (2007) LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 192, 211–217.
11Roche HM & Gibney MJ (2000) Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am J Clin Nutr 71, 232S–237S.
12Calder PC (2004) n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 107, 1–11.
13Psota TL, Gebauer SK & Kris-Etherton P (2006) Dietary omega-3 fatty acid intake and cardiovascular risk. J Am Coll Cardiol 98, 3I–18I.
14Harris WS (1996) n-3 Fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 31, 243–252.
15Minihane AM, Khan S, Leigh-Firbank EC, et al. (2000) ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 20, 1990–1997.
16Griffin BA (2001) The effect of n-3 fatty acids on low density lipoprotein subfractions. Lipids 36, Suppl., S91–S97.
17Hansen JB, Grimsgaard S, Nilsen H, et al. (1998) Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia. Lipids 33, 131–138.
18Mori TA, Burke V, Puddey IB, et al. (2000) Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71, 1085–1094.
19Kelley DS, Siegel D, Vemuri M, et al. (2007) Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 86, 324–333.
20Davidson MH (2006) Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 98, 27I–33I.
21Lu GP, Windsor SL & Harris WS (1999) Omega-3 fatty acids alter lipoprotein subfraction distributions and the in vitro conversion of very low density lipoproteins to low density lipoproteins. J Nutr Biochem 10, 151–158.
22Mostad IL, Bjerve KS, Lydersen S, et al. (2008) Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes. Eur J Clin Nutr 62, 419–429.
23Calder PC (2007) Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 77, 327–335.
24Bulow J, Simonsen L, Wiggins D, et al. (1999) Co-ordination of hepatic and adipose tissue lipid metabolism after oral glucose. J Lipid Res 40, 2034–2043.
25Heath RB, Karpe F, Milne RW, et al. (2003) Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period. J Lipid Res 44, 2065–2072.
26Burdge GC, Sala-Vila A, West AL, et al. (2007) The effect of altering the 20 : 5n-3 and 22 : 6n-3 content of a meal on the postprandial incorporation of n-3 polyunsaturated fatty acids into plasma triacylglycerol and non-esterified fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 77, 59–65.
27Burdge GC, Powell J & Calder PC (2006) Lack of effect of meal fatty acid composition on postprandial lipid, glucose and insulin responses in men and women aged 50–65 years consuming their habitual diets. Br J Nutr 96, 489–500.
28Otvos JD, Jeyarajah EJ & Cromwell WC (2002) Measurement issues related to lipoprotein heterogeneity. Am J Cardiol 90, 22i–29i.
29Couture P, Otvos JD, Cupples LA, et al. (2000) Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 20, 815–822.
30Kraus WE, Houmard JA, Duscha BD, et al. (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347, 1483–1492.
31Brousseau ME, Schaefer EJ, Wolfe ML, et al. (2004) Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med 350, 1505–1515.
32Bhalodkar NC, Blum S, Rana T, et al. (2004) Comparison of levels of large and small high-density lipoprotein cholesterol in Asian Indian men compared with Caucasian men in the Framingham Offspring Study. Am J Cardiol 94, 1561–1563.
33Schaefer EJ, McNamara JR, Tayler T, et al. (2002) Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects. Am J Cardiol 90, 689–696.
34Otvos JD (2002) Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab 48, 171–180.
35Heijmans BT, Beekman M, Houwing-Duistermaat JJ, et al. (2006) Lipoprotein particle profiles mark familial and sporadic human longevity. PLoS Med 3, e495.
36Theobald HE, Goodall AH, Sattar N, et al. (2007) Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. J Nutr 137, 973–978.